News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle-based biotech startup Sana raises $821 million
“I think the most important thing in building a company and the thing that we want inside Sana is finding a mission that will change
Genmab, Seattle Genetics eye FDA filing for new cancer med after latest data drop
Seattle Genetics and Genmab, a Danish biotechnology company, announced a 24% response rate for their joint cervical cancer medication tisotumab vedotin, paving the way for
Sana Biotechnology has big plans after securing $700M initial financing
Sana Biotechnology, a Seattle-based company developing cell and gene therapies, announced it has raised more than $700 million to aid in the discovery and development
This ventilator company vaulted into middle market after $400M government contract
Bothell, Washington’s Ventec Life Systems partnered with General Motors to rapidly scale their ventilator manufacturing capabilities during the onset of COVID-19. They are on track
AbbVie spends $60M, with $80.5M in biobucks, for Alpine Immune’s lupus asset
Seattle-based Alpine Immune Sciences announced a $60M licensing agreement with AbbVie Inc. for its ALPN-101 midstage lupus and autoimmune asset. Under the pact, AbbVie grabs
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
Biomedical Advanced Research and Development Authority (BARDA) announced a collaboration with Seattle’s Immunexpress Inc. to determine the risk of sepsis in hospitalized COVID-19 patients. READ